Author:
Panteli Dimitra,Eckhardt Helene,Nolting Alexandra,Busse Reinhard,Kulig Michael
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Henshall C, Mardhani-Bayne L, Fronsdal KB, Klemp M. Interactions between health technology assessment, coverage, and regulatory processes: emerging issues, goals, and opportunities. Int J Technol Assess Health Care. 2011;27:253–60.
2. Hutton J, McGrath C, Frybourg JM, Tremblay M, Bramley-Harker E, Henshall C. Framework for describing and classifying decision-making systems using technology assessment to determine the reimbursement of health technologies (fourth hurdle systems). Int J Technol Assess Health Care. 2006;22:10–8.
3. Organisation for Economic Co-operation and Development. Health at a Glance 2013. OECD Indicators. 2013. http://www.oecd.org/health/health-systems/health-at-a-glance.htm .
4. Carone G, Schwierz C, Xavier A. Cost-containment policies in public pharmaceutical spending in the EU. European Economy. Economic Papers 461. Brussels: European Commission; 2012. ec.europa.eu/economy_finance/publications/…/ecp_461_en.pdf.
5. Sorenson C, Drummond M, Kanavos P. Ensuring value for money in health care: the role of health technology assessment in the European Union. European Observatory on Health Systems and Policies: Copenhagen; 2008.
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献